S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q4 2024

RTW Investments

Period: Q4 2024 Β· Filed: 2025-02-14
View on SEC EDGAR β†—
AUM
$6.61B
Total portfolio value
Positions
72
Reported securities
Top Holding
MDGL
9.3% $615.2M
QoQ Changes
+8 / -5
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MDGLMADRIGAL PHARMACEUTICALS INC$615.2M9.30%$308.57$528.10+71.1%
9.3%
ARGXARGENX SE$414.2M6.26%$615.00$939.68+52.8%
6.3%
NTRANATERA INC$410.5M6.21%$158.30$279.32+76.5%
6.2%
AXSMAXSOME THERAPEUTICS INC$342.8M5.18%$84.61$244.31+188.8%
5.2%
PTCTPTC THERAPEUTICS INC$333.7M5.05%$45.14$83.31+84.6%
5.0%
RNAMAVIDITY BIOSCIENCES INC$230.7M3.49%β€”β€”
3.5%
RCKTROCKET PHARMACEUTICALS INC$222.3M3.36%$12.57$3.84-69.5%
3.4%
ALKSALKERMES PLC$217.4M3.29%$28.76$54.58+89.8%
3.3%
SYKSTRYKER CORPORATION$212.5M3.21%$354.84$326.54-8.0%
3.2%
PTGXPROTAGONIST THERAPEUTICS INC$212.2M3.21%$38.60$131.62+241.0%
3.2%
INSMINSMED INC$208.1M3.15%$69.04$111.60+61.6%
3.1%
PENPENUMBRA INC$204.8M3.10%$237.48$318.57+34.1%
3.1%
AKROAKERO THERAPEUTICS INC$190.8M2.89%β€”β€”
2.9%
TARSTARSUS PHARMACEUTICALS INC$179.2M2.71%$55.37$65.44+18.2%
2.7%
MRUSMERUS N V$175.3M2.65%β€”β€”
2.6%
ACADACADIA PHARMACEUTICALS INC$159.8M2.42%$18.35$25.97+41.5%
2.4%
BRKRBRUKER CORP$145.4M2.20%$58.19$61.64+5.9%
2.2%
IMCRIMMUNOCORE HLDGS PLC$143.7M2.17%$29.50$32.50+10.2%
2.2%
RDNTRADNET INC$138.2M2.09%$69.84$68.75-1.6%
2.1%
CYTKCYTOKINETICS INC$128.0M1.94%$47.04$86.49+83.9%
1.9%
DYNDYNE THERAPEUTICS INC$123.0M1.86%$23.56$23.07-2.1%
1.9%
APGEAPOGEE THERAPEUTICS INC$122.9M1.86%$45.30$132.91+193.4%
1.9%
ESTAESTABLISHMENT LABS HLDGS INC$118.4M1.79%$46.07$89.25+93.7%
1.8%
MASIMASIMO CORP$113.0M1.71%$165.30β€”
1.7%
VRNAVERONA PHARMA PLC$84.6M1.28%β€”β€”
1.3%
SYRESPYRE THERAPEUTICS INC$84.3M1.28%$23.28$86.63+272.1%
1.3%
RAREULTRAGENYX PHARMACEUTICAL IN$82.8M1.25%$42.07$33.47-20.4%
1.3%
GMEDGLOBUS MED INC$80.4M1.22%$82.71$80.12-3.1%
1.2%
ZLABZAI LAB LTD$65.7M0.99%$26.19$19.12-27.0%
1.0%
ARVNARVINAS INC$63.9M0.97%$19.17$8.39-56.2%
1.0%

Quarter-on-Quarter Activity

Q4 2024 vs. Q3 2024

New Positions (8)

TickerIssuerNotionalSince Filing
VRNAVERONA PHARMA PLC$84.6M
GMEDGLOBUS MED INC$80.4M-3.1%
ZLABZAI LAB LTD$65.7M-27.0%
RAPTRAPT THERAPEUTICS INC$18.6M
CRVSCORVUS PHARMACEUTICALS INC$14.3M
IMVTIMMUNOVANT INC$13.1M
PEPGPEPGEN INC$12.1M
CMPSCOMPASS PATHWAYS PLC$11.7M

Exited Positions (5)

TickerIssuerNotional
GERNGERON CORP$200.3M
GKOSGLAUKOS CORP$50.3M
TEMTEMPUS AI INC$22.6M
TXG10X GENOMICS INC$11.3M
SABSSAB BIOTHERAPEUTICS INC$1.7M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
QUREUNIQURE NV$15.9M+8936.2%
XNCRXENCOR INC$43.7M+317.9%
REPLREPLIMUNE GROUP INC$12.6M+82.1%
SYKSTRYKER CORPORATION$69.1M+48.7%-8.0%
CGONCG ONCOLOGY INC$-1.9M+26.6%
ARVNARVINAS INC$-4.6M+19.8%-56.2%
NGNENEUROGENE INC$-16.8M+18.9%
AKROAKERO THERAPEUTICS INC$21.0M+15.9%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
EPIXESSA PHARMA INC$-17.8M-65.9%
MASIMASIMO CORP$-82.0M-53.3%
SAGESAGE THERAPEUTICS INC$-24.1M-46.3%
TSHATAYSHA GENE THERAPIES INC$-15.0M-42.0%
ACADACADIA PHARMACEUTICALS INC$-51.1M-36.5%+41.5%
IMTXIMMATICS N.V$-67.6M-34.6%
BRKRBRUKER CORP$-95.0M-28.7%+5.9%
DYNDYNE THERAPEUTICS INC$-122.0M-23.5%-2.1%
← Back to Hedge Funds